P. Jenner, Molecular mechanisms of L-DOPA-induced dyskinesia, Nature Reviews Neuroscience, vol.68, issue.9, pp.665-677, 2008.
DOI : 10.1038/nrn2471

M. Cenci, Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia, Trends in Neurosciences, vol.30, issue.5, pp.236-243, 2007.
DOI : 10.1016/j.tins.2007.03.005

P. Calabresi, D. Filippo, M. Ghiglieri, V. Picconi, and B. , Molecular mechanisms underlying levodopa-induced dyskinesia, Movement Disorders, vol.3, issue.S3, pp.570-579, 2008.
DOI : 10.1002/mds.22019

M. Cenci and M. Lundblad, Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia, Journal of Neurochemistry, vol.25, issue.2, pp.381-392, 2006.
DOI : 10.1016/0166-2236(90)90112-N

P. Orban, P. Chapman, and R. Brambilla, Is the Ras-MAPK signalling pathway necessary for long-term memory formation?, Trends in Neurosciences, vol.22, issue.1, pp.38-44, 1999.
DOI : 10.1016/S0166-2236(98)01306-X

S. Fasano and R. Brambilla, Cellular Mechanisms of Striatum-Dependent Behavioral Plasticity and Drug Addiction, Current Molecular Medicine, vol.2, issue.7, pp.649-665, 2002.
DOI : 10.2174/1566524023362005

R. Brambilla, Targeting Ras/ERK signaling in the striatum: will it help?, Molecular Psychiatry, vol.8, issue.4, pp.366-368, 2003.
DOI : 10.1038/sj.mp.4001291

J. Girault, E. Valjent, J. Caboche, and D. Hervé, ERK2: a logical AND gate critical for drug-induced plasticity?, Current Opinion in Pharmacology, vol.7, issue.1, pp.77-85, 2007.
DOI : 10.1016/j.coph.2006.08.012

URL : https://hal.archives-ouvertes.fr/inserm-00128883

J. Westin, L. Vercammen, E. Strome, C. Konradi, and M. Cenci, Spatiotemporal Pattern of Striatal ERK1/2 Phosphorylation in a Rat Model of L-DOPA???Induced Dyskinesia and the Role of Dopamine D1 Receptors, Biological Psychiatry, vol.62, issue.7, pp.800-810, 2007.
DOI : 10.1016/j.biopsych.2006.11.032

E. Santini, Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia, Journal of Neuroscience, vol.27, issue.26, pp.6995-7005, 2007.
DOI : 10.1523/JNEUROSCI.0852-07.2007

N. Pavón, A. Martín, A. Mendialdua, and R. Moratalla, ERK Phosphorylation and FosB Expression Are Associated with L-DOPA-Induced Dyskinesia in Hemiparkinsonian Mice, Biological Psychiatry, vol.59, issue.1, pp.64-74, 2006.
DOI : 10.1016/j.biopsych.2005.05.044

S. Schuster, The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of L-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease, Journal of Neuroscience, vol.28, issue.17, pp.4311-4316, 2008.
DOI : 10.1523/JNEUROSCI.4720-07.2008

J. Sweatt, The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory, Journal of Neurochemistry, vol.16, issue.1, pp.1-10, 2001.
DOI : 10.1046/j.1471-4159.2001.00054.x

S. Davis and S. Laroche, Mitogen-activated protein kinase/extracellular regulated kinase signalling and memory stabilization: a review, Genes, Brain and Behavior, vol.110, issue.2, pp.61-72, 2006.
DOI : 10.1111/j.1601-183X.2006.00230.x

J. Ramos, The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells, The International Journal of Biochemistry & Cell Biology, vol.40, issue.12, pp.2707-2719, 2008.
DOI : 10.1016/j.biocel.2008.04.009

S. Cagnol and J. Chambard, ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence, FEBS Journal, vol.5, issue.1, pp.2-21, 2010.
DOI : 10.1111/j.1742-4658.2009.07366.x

E. Kim and E. Choi, Pathological roles of MAPK signaling pathways in human diseases, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1802, issue.4, pp.396-405, 2010.
DOI : 10.1016/j.bbadis.2009.12.009

URL : https://hal.archives-ouvertes.fr/hal-00566733

S. Fasano, Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) Controls Activation of Extracellular Signal-Regulated Kinase (ERK) Signaling in the Striatum and Long-Term Behavioral Responses to Cocaine, Biological Psychiatry, vol.66, issue.8, pp.758-768, 2009.
DOI : 10.1016/j.biopsych.2009.03.014

R. Brambilla, A role for the Ras signalling pathway in synaptic transmission and long-term memory, Nature, vol.390, pp.281-286, 1997.

M. Lundblad, Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia, Experimental Neurology, vol.194, issue.1, pp.66-75, 2005.
DOI : 10.1016/j.expneurol.2005.02.002

S. Darmopil, A. Martín, D. Diego, I. Ares, S. Moratalla et al., Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA???Induced Dyskinesia and Histone Activation, Biological Psychiatry, vol.66, issue.6, pp.603-613, 2009.
DOI : 10.1016/j.biopsych.2009.04.025

M. Lundblad, B. Picconi, H. Lindgren, and M. Cenci, A model of l-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function, Neurobiology of Disease, vol.16, issue.1, pp.110-123, 2004.
DOI : 10.1016/j.nbd.2004.01.007

E. Valjent, Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties, J Neurosci, vol.20, pp.8701-8709, 2000.

E. Santini, l-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice, Journal of Neurochemistry, vol.20, issue.3, pp.621-633, 2009.
DOI : 10.1111/j.1471-4159.2008.05831.x

C. Konradi, Transcriptome analysis in a rat model of l-DOPA-induced dyskinesia, Neurobiology of Disease, vol.17, issue.2, pp.219-236, 2004.
DOI : 10.1016/j.nbd.2004.07.005

B. Valastro, Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia, Journal of Neurochemistry, vol.62, issue.4, pp.1395-1409, 2007.
DOI : 10.1016/0006-8993(86)90893-0

J. Crittenden, Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy, Proceedings of the National Academy of Sciences, vol.106, issue.8, pp.2892-2896, 2009.
DOI : 10.1073/pnas.0812822106

M. Amendola, M. Venneri, A. Biffi, E. Vigna, and L. Naldini, Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters, Nature Biotechnology, vol.6, issue.1, pp.108-116, 2005.
DOI : 10.1038/nm871

M. Indrigo, A. Papale, D. Orellana, and R. Brambilla, Lentiviral Vectors to Study the Differential Function of ERK1 and ERK2 MAP Kinases, Methods Mol Biol, vol.661, pp.205-220, 2010.
DOI : 10.1007/978-1-60761-795-2_12

G. Krapivinsky, The NMDA Receptor Is Coupled to the ERK Pathway by a Direct Interaction between NR2B and RasGRF1, Neuron, vol.40, issue.4, pp.775-784, 2003.
DOI : 10.1016/S0896-6273(03)00645-7

URL : https://hal.archives-ouvertes.fr/inserm-00484801

M. Vanoni, Characterization and Properties of Dominant-negative Mutants of the Ras-specific Guanine Nucleotide Exchange Factor CDC25Mm, Journal of Biological Chemistry, vol.274, issue.51, pp.36656-36662, 1999.
DOI : 10.1074/jbc.274.51.36656

C. Vantaggiato, ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially, Journal of Biology, vol.5, issue.5, pp.14-15, 2006.
DOI : 10.1016/0092-8674(91)90503-Q

URL : http://doi.org/10.1186/jbiol38

F. Stocchi, M. Tagliati, and C. Olanow, Treatment of levodopa-induced motor complications, Movement Disorders, vol.121, issue.S3, pp.599-612, 2008.
DOI : 10.1002/mds.22052

K. Buck and B. Ferger, l-DOPA-induced dyskinesia in Parkinson's disease: a drug discovery perspective, Drug Discovery Today, vol.15, issue.19-20, pp.19-20867, 2010.
DOI : 10.1016/j.drudis.2010.08.014

H. Bateup, Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors, Proceedings of the National Academy of Sciences, vol.107, issue.33, pp.14845-14850, 2010.
DOI : 10.1073/pnas.1009874107

M. Ahmed, Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease, Science Translational Medicine, vol.2, issue.28, pp.28-28, 2010.
DOI : 10.1126/scitranslmed.3000664

M. Cenci and C. Konradi, Maladaptive striatal plasticity in l-DOPA-induced dyskinesia, Prog Brain Res, vol.183, pp.209-233, 2010.
DOI : 10.1016/S0079-6123(10)83011-0

O. Isacson and J. Kordower, Future of cell and gene therapies for Parkinson's disease, Annals of Neurology, vol.19, issue.S2, pp.122-138, 2008.
DOI : 10.1002/ana.21473

C. Lundberg, Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders, Current Gene Therapy, vol.8, issue.6, pp.461-473, 2008.
DOI : 10.2174/156652308786847996

A. Nanou and M. Azzouz, Gene therapy for neurodegenerative diseases based on lentiviral vectors, Prog Brain Res, vol.175, pp.187-200, 2009.
DOI : 10.1016/S0079-6123(09)17513-1

S. Ramaswamy, K. Soderstrom, and J. Kordower, Trophic factors therapy in Parkinson's disease, Prog Brain Res, vol.175, pp.201-216, 2009.
DOI : 10.1016/S0079-6123(09)17514-3

M. Andersson, C. Konradi, and M. Cenci, cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum, J Neurosci, vol.21, pp.9930-9943, 2001.

O. Berton, Striatal Overexpression of ??JunD Resets L-DOPA-Induced Dyskinesia in a Primate Model of Parkinson Disease, Biological Psychiatry, vol.66, issue.6, pp.554-561, 2009.
DOI : 10.1016/j.biopsych.2009.04.005

E. Bézard, Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function, Nature Medicine, vol.9, issue.6, pp.762-767, 2003.
DOI : 10.1038/nm875

S. Gold, RGS9 2 Negatively Modulates L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia in Experimental Parkinson's Disease, Journal of Neuroscience, vol.27, issue.52, pp.14338-14348, 2007.
DOI : 10.1523/JNEUROSCI.4223-07.2007

T. Boraud, E. Bezard, B. Bioulac, and C. Gross, Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey, Brain, vol.124, issue.3, pp.546-557, 2001.
DOI : 10.1093/brain/124.3.546

C. Guigoni, Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning, European Journal of Neuroscience, vol.49, issue.1, pp.283-287, 2005.
DOI : 10.1111/j.1460-9568.2005.04196.x